From its beginnings in Dr. Oldenziel’s home, Ofichem has grown with care and dedication — always keeping people, progress, and quality at the heart of its journey.
Ofichem was founded in the home of Dr Oldenziel and his wife. The company spent its first year operating from the couple’s garage before moving to an old milk factory for the next decade. The company was officially called Laboratorium Ofichem BV, but was always known as Ofichem, which began as an abbreviation of Oldenziel Fine Chemicals.
The company moved to Heembadweg, Ter Apel – its current location.
Founded Incopharm, as the first affiliated company for sourcing and distribution.
In 2004, Ofichem BV was founded as the second affiliated company for sourcing and distribution. Offices were opened in Paris, France, and Barcelona, Spain.
In 2006, Dr. OH Oldenziel passed away and was succeeded by his son, Dr Weite Oldenziel.
With quality requirements for APIs evolving rapidly in a globalising market, Ofichem reshaped itself with GMP at the core — proving that for us, quality isn’t a promise; it’s a habit built into every detail.
The R&D facilities of Ofichem were expanded and began business as a CDMO.
Ofipharma was founded, the third affiliated company for sourcing and distribution.
From 2018-2020, almost all parts of the company were updated and restructured:
Ofichem built a new R&D lab to expand its already extensive offering.
Ofichem acquired InnoGenerics in Leiden, entering the drug product manufacturing market in oral solid dosage forms. The site in Leiden was renamed Ofimedicine.
Ofichem acquired both Avivia in Nijmegen, strengthening the formulation development capabilities, and OT Chemistry in Uppsala, Sweden, to expand the preclinical drug substance development services and enable a full range of support from early development to commercialisation.
Our acquisitions reflect one mission: to stand beside our partners from early development through to commercialisation. The synergy between the different business units makes Ofichem a strong and stable player in the market. By combining our scientific, innovative skills with our network of distribution activities, we can support partners in solving their challenges in the best possible way.
Ofichem is continuously focused on internationalisation and expansion, offering additional manufacturing capacities and capabilities to serve our international customer base.
Still independent and family-owned, we are ready for the future.
Work shoulder-to-shoulder with a family-owned CDMO and pharmaceutical supplier that answers quickly, solves early, and keeps your progress steady. Decisions feel clearer with us beside you.
